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Edited by Berend WieringaAbstract A monoclonal antibody (mAb) has been produced
which reacts with human mitoﬁlin, a mitochondrial inner mem-
brane protein. This mAb immunocaptures its target protein in
association with six other proteins, metaxins 1 and 2, SAM50,
CHCHD3, CHCHD6 and DnaJC11, respectively. The ﬁrst three
are outer membrane proteins, CHCHD3 has been assigned to
the matrix space, and the other two proteins have not been de-
scribed in mitochondria previously. The functional role of this
new complex is uncertain. However, a role in protein import
related to maintenance of mitochondrial structure is suggested
as mitoﬁlin helps regulate mitochondrial morphology and at least
four of the associated proteins (metaxins 1 and 2, SAM50 and
CHCHD3) have been implicated in protein import, while
DnaJC11 is a chaperone-like protein that may have a similar role.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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At one level, cellular processes are compartmentalized by
their localization to speciﬁc organelles. In addition, it has be-
come clear that these processes are further organized into mul-
ticomponent aggregates within which the product of one
reaction is passed without release to become the substrate of
the next enzyme/reaction. Examples include transcription,
translation protein degradation, protein transport into organ-
elles such as mitochondria and a number of metabolic path-
ways. Oxidative phosphorylation is one of the best
characterized processes in which highly organized protein
aggregates are involved. This important part of energy metab-
olism is catalyzed by electron transfer complexes I, II, III and
IV, which are assemblies of 45, 4, 11 and 13 proteins, respec-
tively [1]. These are further organized into super-complexesAbbreviations: mAb, monoclonal antibody; OXPHOS, oxidative
phosphorylation; HHM, muman heart mitochondria; LM, n-dode-
cyl-b-D-maltopyranoside; SDS–PAGE, sodium dodecyl sulfate–poly-
acrylamide gel electrophoresis; CM, conditioned media; MW,
molecular weight
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is a highly organized multi-protein aggregate that optimally
carries out a sequence of reactions with maximum conservancy
of throughput by limiting competition for and/or protecting
the structural integrity of intermediates generated during the
overall process.
The individual electron transfer complexes represent tight
associations of proteins that co-purify even under strong deter-
gent or salt conditions [4]. This is not always the case with pro-
tein assemblies. A key to identifying any novel assembly is to
be able to eﬀectively sub-fractionate a cell or organellar extract
under conditions mild enough to maintain relatively weak pro-
tein–protein interactions. Monoclonal antibody (mAb) immu-
noprecipitation is one way of accomplishing this. A mAb is
made to a speciﬁc protein, the cell is disrupted, constituents
solubilized, and the mAb used to immunocapture the antigen
along with any associated proteins for identiﬁcation by protein
chemical methods.
Here we provide an example of using mAb immunocapture
to identify novel protein associations in the cell. The work is a
part of our ongoing eﬀorts to generate mAbs against key pro-
teins of mitochondria. We are using a shotgun method in
which whole mitochondria are injected as an antigen mixture
and mAbs capable of immunoprecipitating component pro-
teins are sorted by rigorous screening that includes mass spec-
trometric identiﬁcation of captured proteins after resolution in
SDS–PAGE. Among the proteins immunoreactive in our
study is mitoﬁlin, a mitochondrial inner membrane protein
thought to be involved in mitochondrial morphology mainte-
nance [5]. Three independent mAbs reactive to mitoﬁlin by
Western blotting proved to immunocapture a complex of this
protein along with a consistent set of six other mitochondrial
proteins, including metaxins 1 and 2 [6], SAM50 [7] , coiled-
coil-helix coiled-coil-helix domain 3 and 6 proteins [8,9] and
the chaperonin protein DnaJC11[10]. The likely role of this
complex in mitochondria is discussed.2. Materials and methods
2.1. Human heart mitochondrial samples
Human heart mitochondria (HHM) purchased from Analytical Bio-
logical Systems, Inc. (Wilmington, DE) were prepared by tissue
homogenization and diﬀerential centrifugation according to Pallotti
and Lenaz [11] with minor modiﬁcations. The enriched mitochondria
were used for immunization and following screen assays.blished by Elsevier B.V. All rights reserved.
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HHMwere used as antigen to immunize 3 CSJLF1/J strain mice. All
of the procedures for hybridoma preparation were as described by
Marusich [12]. Subsequent boosts were given at 3–4 week intervals
and the ﬁnal boosts were given at 4 and 3 days before the splenocytes
were harvested. The immune lymphocytes from these mice spleens
were then harvested and fused with myeloma cells to generate the
hybridoma cell lines.
2.3. Solubulization of mitochondria proteins
Mitochondrial proteins were solubilized for immunocapture studies
using 1% n-dodecyl-b-D-maltopyranoside (LM) as described previ-
ously [13].
2.4. Characterization of immunopuriﬁed proteins
Antibody bound beads were prepared as described in Ref. [14]. In a
brief, 0.5 mg solubilized HHM was incubated overnight at 4 C with
individual conditioned media (CM) double coated protein G-agarose
beads (#20398, Pierce). After the mixing step was complete, the CM
speciﬁed antigens were eluted from the beads using 1% sodium dodecyl
sulfate (SDS) and electrophoresed by 10–20% SDS–PAGE. All the
bands of interest were excised manually for further mass spectrometry
(MS) identiﬁcation.
2.5. Sample preparation for mass spectrometry
Interested bands were excised and the in-gel protein samples were re-
duced, alkalized, and digested with 12.5 ng/ll trypsin over night at
37 C. All procedures based on the standard protocol of UCLA Pasa-
row mass spectrometry laboratory. Digested peptides were collected
and dried ready for MS analysis.
2.6. Analysis of peptides by nano-liquid chromatography tandem mass
spectrometry (nLC-MS/MS)
Trypsin digested peptides were analyzed by nLC-MS/MS with data-
dependent acquisition (Q STAR XL; Applied Biosystems, Foster City,
CA). Brieﬂy, after dissolute in 10 ll of 0.1% formic acid, 5% acetoni-
trile (v/v) using either a split-ﬂow HPLC (Ultimate, Dionex, CA) or
a direct pumping HPLC (Eksigent, CA), samples were loaded to a
trapping column (5 lL/min) previously equilibrated for 20 min with
100% A (A, 0.1% formic acid, 5% acetonitrile in water; B, 0.1% formic
acid in acetonitrile) using an independent pump (Swithos on Ultimate
or micropump on Eksigent). Ten minutes after sample loading the ﬂow
was switched (10-port valve, Switchos or Eksigent) such that the trap
was back ﬂushed by the nanoHPLC system. An analytical capillary re-
verse-phase column (75 lm · 10 cm; C18 5 lm, 300 A˚; Microtech, CA)
was equilibrated for 20 min at 300 nl/min with 100% A (A, 0.1% formic
acid, 5% acetonitrile in water; B, 0.1% formic acid in acetonitrile) prior
to the switching event and initiation of a compound linear gradient
ramping to 80% A, 20% B at 8 min; 65% A, 35% B at 30 min; 25%
A, 75% B at 40 min; and 100% A at 41 min. The analytical column ﬂow
was directed to a stainless steel nanoelectrospray emitter (ES301; Prox-
eon, Odense, Denmark) at 2.5 kV for ionization without nebulizer gas.
The mass spectrometer was operated in information-dependent acqui-
sition mode with a survey scan (m/z 400–1500), data-dependent MS/
MS on the two most abundant ions with exclusion after two MS/MS
experiments.
2.7. Data analysis
Individual sequencing experiments were matched to a global protein
sequence database (MSDB) using Mascot software (Matrix Sciences,
London, UK). The search was run under the ‘‘trypsin’’ mode to iden-
tify only tryptic peptides with ﬁxed modiﬁcation of Cys to its carboxy-
amidomethylated form (+57 Da). Variable modiﬁcation of methionine
to its sulfoxide (16 Da) was included. A signiﬁcant probability score
(P < 0.05 = MOWSE score > 63) was required for a secure identity
assignment.Fig. 1. Three newly generated mAbs speciﬁcally immunocaptured
mitoﬁlin along with six other proteins including SAM50 protein
(sorting and assembly machinery component 50 homolog), MTX1&2
(metaxins 1 and 2), CHCHD3&6 (coiled-coil-helix coiled-coil-helix
domain-containing protein 3 and 6), and DnaJC11 (DnaJ homolog
subfamily C member 11). *Silver stain result.2.8. Sucrose gradient fractionation
To conﬁrm the tight association of the newly identiﬁed mitoﬁlin
complex, and to determine whether or not the putative complex was
an artifact due to mAb cross-reactivity to all proteins, sucrose gradient
fractionation combined with Western blot and immune precipitation
were performed. The distribution of the mitoﬁlin complex in sucrosegradient fractions, and from this its approximate molecular weight,
was determined by reference to that of the well known oxidative phos-
phorylation (OXPHOS) complexes [15]. In brief, solubilized HHMwas
loaded on the top of 4.5 ml of 15–35% sucrose gradient. After 16.5 h
centrifugation at 128000 · g at 4 C, the sucrose gradient was frac-
tioned to 10 equal volume aliquots. The proteins in each fraction were
then separated on 1D-SDS–PAGE gel. Mitoﬁlin speciﬁc antibody
(MM#7A-2E4AD5) was used as primary antibody to reveal location
of the mitoﬁlin complex. The OXPHOS complexes of mitochondria
were blotted in parallel using the OXPHOS complex detection kit
(#MS601, MitoSciences Inc. Eugene, OR). Western blotting was per-
formed according to the manufacturer’s recommended protocol. The
mitoﬁlin-enriched fractions were also further analyzed by immunocap-
ture using the mitoﬁlin antibody followed by SDS–PAGE.3. Results
Human heart mitochondria were used as a mixture to gener-
ate mAbs to highly antigenic proteins of mitochondria. Among
these were mAbs that immunocaptured each of the complexes
of oxidative phosphorylation, proteins of apoptosis, Krebs
cycle enzymes and enzymes of fatty acid oxidation. In addition
to these previously known protein complexes, we identiﬁed
mAbs that immunoprecipitate a novel multiprotein complex,
which described as mitoﬁlin complex here.
Three hybridomas generated mAbs that immunocaptured a
protein complex showing the same set of component proteins
of apparent molecular weight (MW) ranging from 83 kDa to
26 kDa. Gel bands were excised from SDS–PAGE gels and
subjected to nLC-MS/MS. Fig. 1 shows the resolution of the
several protein bands and lists the components in each band
Table 1
The protein identiﬁcation result from MM#2E4AD5, 3A9 and 1A1CF5 using nLC-MS/MS
No. Gene name Protein name MW PI AA Mowse score Sequence coverage (%)
M1 IMMT mitoﬁlin 82564 6.15 747 1596 44
M2 DNAJC11 DnaJ (Hsp40) homolog subfamily C member 11. 63278 8.54 559 839 30
M3 SAM50 51872 6.44 468 351 13
CHCHD3 dimer 26136 8.48 227 302 18
M4 SAM50 51872 6.44 468 668 50
M5 MTX1 Metaxin-1 35754 5.9 317 316 22
M6 CHCHD6 Coiled-coil-helix coiled-coil-helix domain-containing protein 6 26441 9.01 235 255 30
M7 CHCHD3 Coiled-coil-helix coiled-coil-helix domain-containing protein 3 26136 8.48 227 583 26
M8 MTX2 Metaxin-2 29744 5.9 263 639 37
M9 IgG Lamda light chain 22547 5.79 213 222 17
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components were consistently identiﬁed in the same bands in
multiple immunoprecipitations and were the proteins mitoﬁlin,
DnaJC11, SAM50, metaxin 1, coiled-coil-helix coiled-coil-he-
lix domain 6 protein (CHCHD6), coiled-coil-helix coiled-
coil-helix domain 3 (CHCHD3) and metaxin 2 in order of
molecular weight. To identify which protein in the complex
was speciﬁcally recognized by each of the three mitoﬁlin com-
plex capture mAbs, Western blots were done using HHM as
samples. In each case, the only band recognized was the
83 kDa mitoﬁlin protein (Fig. 2a). To ensure the mitoﬁlin
monospeciﬁcity was not due to a lack of target material, the
complex was ﬁrst immunocaptured, and the immunoprecipi-
tate subjected to Western blot analysis using the same capture
mAb to probe the blot. As shown in Fig. 2b, the mAb again
reacted monospeciﬁcally against mitoﬁlin.
To conﬁrm the tight association of the newly identiﬁed
mitoﬁlin complex in the absence of mAb binding, sucrose gra-Fig. 2a. Using whole human heart mitochondria as sample, three
newly generated mAbs recognized a single 83 kDa protein on Western
blot identiﬁed by mass spectrometry as mitoﬁlin.dient fractionation was performed on solubilized HHM. This
approach also provides a measure of the size of the mitoﬁlin
complex. Sucrose gradient fractionation separates protein com-
plexes mainly by size but with a contribution from buoyant
density related to lipid/protein/detergent ratios. Fig. 3 shows
a typical result, with the ﬁve complexes of OXPHOS resolved
across the gradient (identiﬁed by Western blotting). The mitoﬁ-
lin reactive mAb (applied during the Western blotting, not dur-
ing running of the sucrose gradient) showed that the mitoﬁlin-
containing complex was eluted mainly in fractions 5, 6 and 7,
thereby eluting as larger than complex II (MW 100 kDa) but
smaller than F1ATPase (350 kDa) or the cytochrome c oxidase
(Complex IV) dimer (400 kDa). This is consistent with a com-
plex containing all six proteins with CHCHD3 as a dimer
(aggregate MW 340 kDa). Finally, the anti-mitoﬁlin mAb
was used to immunocapture the complex from the three mitoﬁ-
lin-enriched sucrose gradient fractions i.e. from fractions 5, 6Fig. 2b. The left three lanes present the Coomassie stained immuno-
precipitation result using the three new generated mitoﬁlin mAbs. The
right three lanes are the Western blot result using mitoﬁlin mAb
(2E4AD5) to blot the immunocaptured mitoﬁlin complex, which
conﬁrms that mitoﬁlin is the target antigen.
Fig. 3. The complex-relationship of mitoﬁlin with the other ﬁve
proteins was conﬁrmed by sucrose gradient fractionation. The distri-
bution of mitoﬁlin was detected with newly generated antibody
(2E4AD5) on PVDF membrane. The comparable distribution of
OXPHOS complexes were blotted with total OXPHOS complex
detection kit from MitoSciences Inc. The distribution of OXPHOS
complex was labeled as reference. The mitoﬁlin was further immune
captured from its enriched sucrose gradient fractions (fraction 5–7).
The immune puriﬁed proteins from each fraction repeated the identical
gel pattern on 1D-SDS–PAGE as the one immunocaptured from the
whole human heart mitochondria (see Fig. 1).
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anti-mitoﬁlin mAb immunocaptured the same mitoﬁlin com-
plex containing all six proteins with the identical gel pattern
to that when the complex was immunocaptured directly from
the total mitochondrial protein sample.4. Discussion
Mitoﬁlin has been studied in several laboratories and char-
acterized as an inner membrane protein with both coiled coil
and inter-membrane space-targeting domains [16]. It is
thought to function in mitochondrial cristae morphology [5].
This protein is reduced signiﬁcantly in fetal Down’s syndrome
brain [17]. Present in association with mitoﬁlin as immunocap-
tured here are so-called coiled-coil-helix coiled-coil-helix do-
main 3 and 6 proteins (CHCHD3 and CHCHD6) whose
functions are poorly understood [8,9]. CHCHD3 has been
identiﬁed before in mitochondria and tentatively assigned to
the matrix space.
Three other proteins in this complex are metaxins 1 and 2
along with SAM 50 protein all of which have been character-
ized as outer membrane proteins. Metaxins 1 and 2 locate on
the cytosol side of the outer membrane and serve in protein
precursor import into mitochondria. Metaxin 2 is peripherally
associates with mitochondrial outer membrane by means of its
interaction with membrane-bound metaxin 1 protein. Neither
of them associates directly with the TOM complex, but shares
a limited homology with SAM37 protein, a subunit of the
complex in the outer membrane responsible for beta-barrel
protein import and assembly into the organelle [6,18,19]. Me-
taxin has been identiﬁed as a key factor in the tumor necrosisfactor (TNF)-induced cell death [20]. SAM50 protein (sorting
and assembly machinery component 50 homolog), the third
component of outer membrane proteins in the complex, is also
a beta-barrel protein and was shown to be required for incor-
poration of the TOM40 precursor into the mature TOM com-
plex [21], in yeast, Sam50 is a core component of the SAM
complex, which also includes SAM35 and SAM37 as subunits
[7]. However, so far no homologue of Sam37 or Sam35 was
identiﬁed in human samples. The most recent work of Koz-
jak-Pavlovic et al. observed that both Sam50 and metaxins 1
and 2 function in TOM40 and VDAC biogenesis [22]. The ﬁnal
protein identiﬁed as associated with mitoﬁlin is DnaJC11 a
protein identiﬁed only based on its gene sequence and a novel
protein of mitochondria. DnaJC11 is one of the member pro-
teins in 40 kDa heat shock protein subfamily C [23], and so
may be a molecular chaperone during mitochondrial protein
import and folding.
The immunocapture of the above proteins together by three
independent anti-mitoﬁlin mAbs and the co-elution of these
proteins in sucrose gradient centrifugation provide strong
but not deﬁnitive evidence of complex formation and it would
be useful to have mAbs to components other than mitoﬁlin for
conﬁrmatory immunocapture experiments but these reagents
are not yet available. However, consistent with our results,
John et al. reported that mitoﬁlin is part of a supramolecular
complex [5]. However, no proteomic analysis was done in that
work to identify any non-mitoﬁlin members of the complex.
In summary, our results emphasize the utility of the ‘divide
and conquer’ approach we call focused proteomics for identi-
fying mitochondrial proteins and protein–protein interactions.
The approach has previously been used successfully to analyze
the composition and post-translational modiﬁcations of
known mitochondrial enzyme complexes (reviewed in
[14,24]), and now has been used to identify the novel mito-
chondrial protein complex. In addition, two of the proteins de-
scribed here as members of the putative mitoﬁlin complex,
DnaJC11 and CHCHD6, have not been identiﬁed previously
with the organelle.Appendix A. Supplementary data
Supplementary data associated with this article can be
found, in the online version, at doi:10.1016/j.febslet.2007.
06.052.References
[1] Janssen, R.J., Nijtmans, L.G., van den Heuvel, L.P. and Smeitink,
J.A. (2006) Mitochondrial complex I: structure, function and
pathology. J. Inherit. Metab. Dis. 29, 499–515, Epub 2006 July
11.
[2] Boekema, E.J. and Braun, H.P. (2007) Supramolecular structure
of the mitochondrial oxidative phosphorylation system. J. Biol.
Chem. 282, 1–4, Epub 2006 Nov. 13.
[3] Gilkerson, R.W., Selker, J.M. and Capaldi, R.A. (2003) The
crystal membrane of mitochondria is the principal site of
oxidative phosphorylation. FEBS Lett. 546, 355–358.
[4] Myasoedova, K.N., Arutyunyan, A.M. and Magretova, N.N.
(2006) Phenomenon of activation of cytochrome P450 by
nonionic detergents. Biosci. Rep. 26, 69–78.
[5] John, G.B., Shang, Y., et al. (2005) The mitochondrial inner
membrane protein mitoﬁlin controls cristae morphology. Mol.
Biol. Cell 16, 1543–1554, Epub 2005 Jan. 12.
J. Xie et al. / FEBS Letters 581 (2007) 3545–3549 3549[6] Abdul, K.M., Terada, K., Yano, M., Ryan, M.T., Streimann, I.,
Hoogenraad, N.J. and Mori, M. (2000) Functional analysis of
human metaxin in mitochondrial protein import in cultured cells
and its relationship with the Tom complex. Biochem. Biophys.
Res. Commun. 276, 1028–1034.
[7] Kozjak, V., Wiedemann, N., Milenkovic, D., Lohaus, C., Meyer,
H.E., Guiard, B., Meisinger, C. and Pfanner, N. (2000) An
essential role of Sam50 in the protein sorting and assembly
machinery of the mitochondrial outer membrane. J. Biol. Chem.
278, 48520–48523, Epub 2003 Oct. 21.
[8] Dreger, M., Mika, J., Bieller, A., Jahnel, R., Gillen, C., Schaefer,
M.K., Weihe, E. and Hucho, F. (2005) Analysis of the dorsal
spinal cord synaptic architecture by combined proteome analysis
and in situ hybridization. J. Proteome Res. 4, 238–249.
[9] Gerhard, D.S., Wagner, L., et al. (2004) The status, quality, and
expansion of the NIH full-length cDNA project: the Mammalian
Gene Collection (MGC). Genome Res. 14, 2121–2127.
[10] Gregory, S.G., Barlow, K.F., et al. (2006) The DNA sequence
and biological annotation of human chromosome 1. Nature 441,
315–321.
[11] Pallotti, F. and Lenaz, G. (2001) Isolation and subfractionation of
mitochondria from animal cells and tissue culture lines. Methods
Cell Biol. 65, 1–35.
[12] Marusich, M.F. (1998) Eﬃcient hybridoma production using
previously frozen splenocytes. J. Immunol. Methods 114, 155–159.
[13] Aggeler, R., Coons, J., Taylor, S.W., Ghosh, S.S., Garcia, J.J.,
Capaldi, R.A. and Marusich, M.F. (2002) A functionally active
human F1F0 ATPase can be puriﬁed by immunocapture from
heart tissue and ﬁbroblast cell lines. Subunit structure and activity
studies. J. Biol. Chem. 277, 33906–33912, Epub 2002 July 10.
[14] Murray, J., Yonally, S., Aggeler, R., Marusich, M.F. and
Capaldi, R.A. (2004) Focused proteomics: towards a high
throughput monoclonal antibody-based resolution of proteins
for diagnosis of mitochondrial diseases. Biochim. Biophys. Acta
1659, 206–211.
[15] Taylor, S.W. et al. (2002) An alternative strategy to determine the
mitochondrial proteome using sucrose gradient fractionation and1D PAGE on highly puriﬁed human heart mitochondria. J.
Proteome Res. 1, 451–458.
[16] Odgren, P.R., Toukatly, G., Bangs, P.L., Gilmore, R. and Fey,
E.G. (1996) Molecular characterization of mitoﬁlin (HMP), a
mitochondria-associated protein with predicted coiled coil and
intermembrane space targeting domains. J. Cell Sci. 109, 2253–
2264.
[17] Myung, J.K., Gulesserian, T., Fountoulakis, M. and Lubec, G.
(2003) Deranged hypothetical proteins Rik protein, Nit protein 2
and mitochondrial inner membrane protein, Mitoﬁlin, in fetal
Down syndrome brain. Cell. Mol. Biol. (Noisy-le-grand) 49, 739–
746.
[18] Armstrong, L.C., Komiya, T., Bergman, B.E., Mihara, K. and
Bornstein, P. (1997) Metaxin is a component of a preprotein
import complex in the outer membrane of the mammalian
mitochondrion. J. Biol. Chem. 272, 6510–6518.
[19] Armstrong, L.C., Saenz, A.J. and Bornstein, P. (1999) Metaxin 1
interacts with metaxin 2, a novel related protein associated with
the mammalian mitochondrial outer membrane. J. Cell. Biochem.
74, 11–22.
[20] Wang, X., Ono, K., Kim, S.O., Kravchenko, V., Lin, S.C. and
Han, J. (2001) Metaxin is required for tumor necrosis factor-
induced cell death. EMBO Rep. 2, 628–633, Epub 2001 July 3.
[21] Humphries, A.D., Streimann, I.C., Stojanovski, D., Johnston,
A.J., Yano, M., Hoogenraad, N.J. and Ryan, M.T. (2005)
Dissection of the mitochondrial import and assembly pathway
for human Tom40. J. Biol. Chem. 280, 11535–11543, Epub 2005
Jan. 10.
[22] Kozjak-Pavlovic, V., Ross, K., Benlasfer, N., Kimmig, S., Karlas,
A. and Rudel, T. (2007) Conserved roles of Sam50 and metaxins
in VDAC biogenesis. EMBO Rep. 18, 18.
[23] See http://www.expasy.org/cgi-bin/get-sprot-entry?Q9NVH1.
[24] Murray, J., Marusich, M.F., Capaldi, R.A. and Aggeler, R.
(2004) Focused proteomics: monoclonal antibody-based isolation
of the oxidative phosphorylation machinery and detection of
phosphoproteins using a ﬂuorescent phosphoprotein gel stain.
Electrophoresis 25, 2520–2525.
